Linavonkibart

(Synonyms: SRK-181)
고객리뷰

Based on 1 Customer Validation

Linavonkibart (SRK-181) is a fully human IgG4/κ subtype monoclonal antibody that selectively targets latent TGFβ1 (latent TGFβ1), with IC50 values of 1.07 nM, 1.11 nM, and 1.02 nM against human, rat, and cynomolgus monkey orthologs, respectively. Linavonkibart specifically binds to the prodomain of latent TGFβ1, preventing its activation into the mature, active form, and shows negligible binding to TGFβ2, TGFβ3, or activated TGFβ. Linavonkibart is applicable for research on locally advanced or metastatic solid tumors.

연구목적의 판매만을 진행합니다. 환자를 대상으로 한 판매는 하지 않습니다.

  • 보관:
    Shipping with dry ice

    Please store the product under the recommended conditions in the Certificate of Analysis.

  • Biological Activity
  • Chemical Information
  • 순도&문서
  • References
  • Help & FAQs

All TGF-beta/Smad Isoforms

More
MOQ
Minimum order quantity
100 mg

견적 받기 해외재고보유

Other size
견적 받기
Please select quantity
Amount: USD 0.00